These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Incorporation of radiocopper into ceruloplasmin in normal subjects and in patients with primary biliary cirrhosis and Wilson's disease. Vierling JM; Shrager R; Rumble WF; Aamodt R; Berman MD; Jones EA Gastroenterology; 1978 Apr; 74(4):652-60. PubMed ID: 631501 [No Abstract] [Full Text] [Related]
24. Orcein positive hepatocellular material in long-standing biliary diseases. I. Histochemical characteristics. Sipponen P Scand J Gastroenterol; 1976; 11(6):545-52. PubMed ID: 62382 [TBL] [Abstract][Full Text] [Related]
26. Hepatic subcellular distribution of copper in primary biliary cirrhosis. Comparison with other hyperhepatocupric states and review of the literature. Owen CA; Dickson ER; Goldstein NP; Baggenstoss AH; McCall JT Mayo Clin Proc; 1977 Feb; 52(2):73-80. PubMed ID: 345001 [No Abstract] [Full Text] [Related]
27. [Treatment of chronic hepatitis and primary biliary liver cirrhosis with D-penicillamine]. Mansurov KhKh; Mirodzhov GK; Ladnaia MM Klin Med (Mosk); 1981 Feb; 59(2):91-5. PubMed ID: 7289493 [No Abstract] [Full Text] [Related]
28. Liver copper in health and disease. Epstein O Postgrad Med J; 1983; 59 Suppl 4():88-94. PubMed ID: 6647221 [No Abstract] [Full Text] [Related]
29. Correlation between disappearance of the intrahepatic bile ducts and histologic changes in the liver in primary biliary cirrhosis. Nakanuma Y; Miyamura H; Ohta G; Kobayashi K; Kato Y; Hattori N Am J Gastroenterol; 1981 Dec; 76(6):506-10. PubMed ID: 7331981 [TBL] [Abstract][Full Text] [Related]
30. Hair copper in primary biliary cirrhosis. Epstein O; Boss AM; Lyon TD; Sherlock S Am J Clin Nutr; 1980 May; 33(5):965-7. PubMed ID: 7369167 [TBL] [Abstract][Full Text] [Related]
31. Primary biliary cirrhosis. Triger DR Br Med J (Clin Res Ed); 1982 Jun; 284(6333):1898-900. PubMed ID: 6282386 [No Abstract] [Full Text] [Related]
32. Investigations by the use of radioactive copper (64Cu) in chronic liver diseases. Wysocki K; Owczarek L; Górski S; Kurnatowska A Pol Med J; 1969; 8(1):43-9. PubMed ID: 5782169 [No Abstract] [Full Text] [Related]
33. [Therapy of primary biliary cirrhosis]. Jenss H Dtsch Med Wochenschr; 1980 Apr; 105(15):533-4. PubMed ID: 7363825 [No Abstract] [Full Text] [Related]
34. A long-term follow-up study of the hepatic copper and serum ceruloplasmin concentrations in patients with chronic liver disease. Ritland S; Skrede S; Johansen O Scand J Gastroenterol; 1982 Jun; 17(4):545-51. PubMed ID: 7134882 [TBL] [Abstract][Full Text] [Related]
35. Primary biliary cirrhosis: critical evaluation and treatment policies. Sherlock S Scand J Gastroenterol Suppl; 1982; 77():63-74. PubMed ID: 6750830 [TBL] [Abstract][Full Text] [Related]
36. Elevation of ceruloplasmin activity involved in changes of hepatic metal concentration in primary biliary cirrhosis. Sogawa K; Yamada T; Suzuki Y; Masaki T; Watanabe S; Uchida Y; Arima K; Nishioka M; Matsumoto K Res Commun Chem Pathol Pharmacol; 1994 Jun; 84(3):367-70. PubMed ID: 7938909 [TBL] [Abstract][Full Text] [Related]
37. Immune complexes and the treatment of biliary cirrhosis. Resnick RH N Engl J Med; 1979 Jun; 300(26):1487. PubMed ID: 449892 [No Abstract] [Full Text] [Related]